IMMUCELL CORP /DE/ Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Immucell Corp /De/ quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Immucell Corp /De/ Entity Common Stock, Shares Outstanding for the quarter ending October 30, 2024 was 8.91M shares, a 15% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.91M +1.16M +15% Oct 30, 2024 10-Q 2024-11-13
Q2 2024 7.83M +86.2K +1.11% Aug 2, 2024 10-Q 2024-08-13
Q1 2024 7.75M +4K +0.05% Mar 8, 2024 10-K 2024-04-01
Q3 2023 7.75M +4K +0.05% Nov 1, 2023 10-Q 2023-11-13
Q2 2023 7.75M 0 0% Aug 4, 2023 10-Q 2023-08-10
Q1 2023 7.75M +4K +0.05% Mar 10, 2023 10-K 2023-03-29
Q3 2022 7.75M +5K +0.07% Nov 3, 2022 10-Q 2022-11-21
Q2 2022 7.75M +5K +0.07% Aug 2, 2022 10-Q/A 2022-11-21
Q1 2022 7.74M +522K +7.23% Mar 18, 2022 10-K 2022-03-30
Q3 2021 7.74M +529K +7.33% Oct 28, 2021 10-Q 2021-11-15
Q2 2021 7.74M +529K +7.33% Jul 30, 2021 10-Q 2021-08-12
Q1 2021 7.22M +7.92K +0.11% Mar 19, 2021 10-K 2021-03-30
Q3 2020 7.21M +3.32K +0.05% Oct 30, 2020 10-Q 2020-11-12
Q2 2020 7.21M +3.32K +0.05% Aug 4, 2020 10-Q 2020-08-12
Q1 2020 7.21M +1.64M +29.4% Mar 19, 2020 10-K 2020-03-27
Q3 2019 7.21M +1.72M +31.4% Nov 5, 2019 10-Q 2019-11-12
Q2 2019 7.21M +1.73M +31.5% Aug 1, 2019 10-Q 2019-08-12
Q1 2019 5.57M +93.1K +1.7% Mar 18, 2019 10-K 2019-03-22
Q3 2018 5.48M +433K +8.58% Nov 5, 2018 10-Q 2018-11-13
Q2 2018 5.48M +435K +8.62% Aug 8, 2018 10-Q 2018-08-13
Q1 2018 5.48M +632K +13% Mar 20, 2018 10-K 2018-03-29
Q3 2017 5.05M +204K +4.21% Nov 6, 2017 10-Q 2017-11-13
Q2 2017 5.05M +869K +20.8% Aug 9, 2017 10-Q 2017-08-14
Q1 2017 4.85M +670K +16% Mar 20, 2017 10-K 2017-03-30
Q3 2016 4.85M +1.79M +58.7% Nov 8, 2016 10-Q 2016-11-10
Q2 2016 4.18M +1.12M +36.8% Aug 9, 2016 10-Q 2016-08-11
Q1 2016 4.18M +1.15M +38% Mar 17, 2016 10-K 2016-03-25
Q3 2015 3.06M +28K +0.93% Nov 9, 2015 10-Q 2015-11-12
Q2 2015 3.06M +28K +0.93% Aug 10, 2015 10-Q 2015-08-13
Q1 2015 3.03M +1K +0.03% Mar 18, 2015 10-K 2015-03-26
Q3 2014 3.03M +8K +0.27% Nov 7, 2014 10-Q 2014-11-12
Q2 2014 3.03M +8K +0.27% Aug 8, 2014 10-Q 2014-08-13
Q1 2014 3.03M +8K +0.27% Mar 19, 2014 10-K 2014-03-26
Q3 2013 3.02M 0 0% Nov 8, 2013 10-Q 2013-11-13
Q2 2013 3.02M 0 0% Aug 8, 2013 10-Q 2013-08-13
Q1 2013 3.02M 0 0% Mar 20, 2013 10-K 2013-03-28
Q3 2012 3.02M +18.4K +0.61% Nov 13, 2012 10-Q 2012-11-13
Q2 2012 3.02M +35.4K +1.19% Aug 13, 2012 10-Q/A 2012-09-07
Q1 2012 3.02M Mar 26, 2012 10-K 2012-03-27
Q3 2011 3M Nov 11, 2011 10-Q 2011-11-14
Q2 2011 2.98M Aug 12, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.